| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Microphthalmia-Associated Transcription Factor | 58 | 2024 | 259 | 11.230 |
Why?
|
| Melanocytes | 57 | 2024 | 509 | 10.160 |
Why?
|
| Melanoma | 102 | 2024 | 5697 | 8.970 |
Why?
|
| Ultraviolet Rays | 22 | 2021 | 1079 | 4.910 |
Why?
|
| Skin Pigmentation | 16 | 2021 | 277 | 4.880 |
Why?
|
| Skin Neoplasms | 40 | 2024 | 5812 | 3.830 |
Why?
|
| Melanins | 16 | 2020 | 289 | 2.850 |
Why?
|
| Hair Color | 8 | 2021 | 131 | 2.640 |
Why?
|
| Nevus, Pigmented | 3 | 2023 | 222 | 2.160 |
Why?
|
| Proto-Oncogene Proteins B-raf | 25 | 2021 | 2057 | 2.110 |
Why?
|
| Nevus | 4 | 2024 | 205 | 1.990 |
Why?
|
| Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 13 | 2018 | 318 | 1.940 |
Why?
|
| Hair Follicle | 7 | 2021 | 211 | 1.880 |
Why?
|
| Molecular Targeted Therapy | 13 | 2020 | 2812 | 1.840 |
Why?
|
| Gene Expression Regulation, Neoplastic | 31 | 2024 | 8542 | 1.730 |
Why?
|
| Receptor, Melanocortin, Type 1 | 10 | 2022 | 74 | 1.710 |
Why?
|
| Skin | 14 | 2018 | 4473 | 1.550 |
Why?
|
| Stem Cells | 10 | 2021 | 3516 | 1.350 |
Why?
|
| Vitiligo | 3 | 2020 | 96 | 1.240 |
Why?
|
| DNA-Binding Proteins | 25 | 2015 | 9586 | 1.150 |
Why?
|
| Pigmentation | 10 | 2021 | 144 | 1.130 |
Why?
|
| Transcription Factors | 29 | 2015 | 12116 | 1.080 |
Why?
|
| Immunotherapy | 11 | 2023 | 4642 | 1.060 |
Why?
|
| Cell Differentiation | 22 | 2021 | 11514 | 0.990 |
Why?
|
| Sarcoma, Clear Cell | 5 | 2023 | 72 | 0.990 |
Why?
|
| Proto-Oncogene Proteins c-kit | 6 | 2015 | 727 | 0.970 |
Why?
|
| Transcription, Genetic | 18 | 2024 | 7583 | 0.960 |
Why?
|
| Signal Transduction | 39 | 2024 | 23416 | 0.950 |
Why?
|
| Piperazines | 6 | 2013 | 2521 | 0.890 |
Why?
|
| Indoles | 16 | 2017 | 1830 | 0.880 |
Why?
|
| Serpins | 2 | 2015 | 247 | 0.860 |
Why?
|
| Cell Line, Tumor | 45 | 2024 | 16967 | 0.860 |
Why?
|
| Oncogenes | 6 | 2020 | 1221 | 0.840 |
Why?
|
| Promoter Regions, Genetic | 22 | 2017 | 5780 | 0.830 |
Why?
|
| Sunlight | 4 | 2015 | 337 | 0.820 |
Why?
|
| Animals | 97 | 2024 | 168201 | 0.800 |
Why?
|
| Drug Resistance, Neoplasm | 13 | 2023 | 5304 | 0.790 |
Why?
|
| Nerve Growth Factors | 2 | 2015 | 564 | 0.790 |
Why?
|
| Nevus, Epithelioid and Spindle Cell | 1 | 2023 | 70 | 0.780 |
Why?
|
| Gene Expression Regulation | 15 | 2016 | 11874 | 0.770 |
Why?
|
| Endorphins | 1 | 2021 | 74 | 0.760 |
Why?
|
| High-Throughput Screening Assays | 3 | 2017 | 933 | 0.760 |
Why?
|
| Eye Proteins | 2 | 2015 | 632 | 0.750 |
Why?
|
| Behavior, Addictive | 2 | 2018 | 462 | 0.730 |
Why?
|
| Keratinocytes | 7 | 2019 | 790 | 0.720 |
Why?
|
| Sulfonamides | 13 | 2017 | 1977 | 0.710 |
Why?
|
| Isocitrate Dehydrogenase | 3 | 2024 | 937 | 0.710 |
Why?
|
| Transforming Growth Factor beta1 | 2 | 2017 | 630 | 0.710 |
Why?
|
| Mice | 63 | 2024 | 81368 | 0.710 |
Why?
|
| Antineoplastic Agents | 17 | 2023 | 13635 | 0.700 |
Why?
|
| Sunbathing | 2 | 2011 | 65 | 0.700 |
Why?
|
| Drug Screening Assays, Antitumor | 2 | 2013 | 717 | 0.690 |
Why?
|
| Cell Transformation, Neoplastic | 7 | 2024 | 2821 | 0.690 |
Why?
|
| Transcriptional Activation | 7 | 2017 | 1755 | 0.660 |
Why?
|
| GTP Phosphohydrolases | 6 | 2021 | 517 | 0.660 |
Why?
|
| Pigmentation Disorders | 1 | 2020 | 105 | 0.650 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 6 | 2019 | 1404 | 0.640 |
Why?
|
| Zebrafish | 8 | 2024 | 3007 | 0.630 |
Why?
|
| Histocompatibility Antigens | 1 | 2020 | 464 | 0.630 |
Why?
|
| Protein Kinase Inhibitors | 10 | 2021 | 5672 | 0.620 |
Why?
|
| Medical Oncology | 3 | 2024 | 2317 | 0.620 |
Why?
|
| Neural Crest | 6 | 2018 | 279 | 0.620 |
Why?
|
| Humans | 171 | 2024 | 760617 | 0.620 |
Why?
|
| Reactive Oxygen Species | 2 | 2024 | 2137 | 0.600 |
Why?
|
| Cell Lineage | 8 | 2012 | 2554 | 0.590 |
Why?
|
| Genes, ras | 4 | 2018 | 654 | 0.590 |
Why?
|
| Dermatitis, Irritant | 1 | 2017 | 18 | 0.590 |
Why?
|
| Nuclear Receptor Subfamily 1, Group F, Member 1 | 1 | 2017 | 49 | 0.570 |
Why?
|
| Proto-Oncogene Proteins c-met | 5 | 2014 | 571 | 0.570 |
Why?
|
| Glycogen Synthase Kinase 3 | 1 | 2019 | 411 | 0.550 |
Why?
|
| beta-Endorphin | 2 | 2014 | 43 | 0.540 |
Why?
|
| Neoplasm Proteins | 9 | 2014 | 3607 | 0.540 |
Why?
|
| Xanthones | 1 | 2016 | 23 | 0.540 |
Why?
|
| Gene Amplification | 5 | 2014 | 1087 | 0.530 |
Why?
|
| Mutation | 30 | 2024 | 30016 | 0.510 |
Why?
|
| Zebrafish Proteins | 4 | 2024 | 1015 | 0.510 |
Why?
|
| Histone-Lysine N-Methyltransferase | 1 | 2020 | 682 | 0.510 |
Why?
|
| Dermatologic Agents | 1 | 2020 | 313 | 0.510 |
Why?
|
| Enzyme Inhibitors | 6 | 2021 | 3705 | 0.500 |
Why?
|
| Receptors, Platelet-Derived Growth Factor | 1 | 2015 | 178 | 0.490 |
Why?
|
| Monophenol Monooxygenase | 6 | 2021 | 72 | 0.490 |
Why?
|
| Malate Dehydrogenase | 1 | 2015 | 40 | 0.490 |
Why?
|
| Pyrimidines | 4 | 2013 | 3027 | 0.490 |
Why?
|
| Skin Diseases | 3 | 2018 | 1094 | 0.480 |
Why?
|
| DNA Damage | 6 | 2024 | 2446 | 0.480 |
Why?
|
| PPAR gamma | 1 | 2017 | 484 | 0.460 |
Why?
|
| Cell Proliferation | 17 | 2021 | 10432 | 0.460 |
Why?
|
| Neoplasm Invasiveness | 5 | 2015 | 3593 | 0.460 |
Why?
|
| MicroRNAs | 6 | 2021 | 3805 | 0.450 |
Why?
|
| Niacinamide | 1 | 2016 | 413 | 0.450 |
Why?
|
| Histone Deacetylase Inhibitors | 3 | 2021 | 774 | 0.440 |
Why?
|
| Membrane Proteins | 10 | 2018 | 7847 | 0.440 |
Why?
|
| SOXE Transcription Factors | 6 | 2024 | 73 | 0.440 |
Why?
|
| Mice, Inbred C57BL | 20 | 2021 | 22115 | 0.430 |
Why?
|
| Neoplasms, Radiation-Induced | 3 | 2014 | 549 | 0.420 |
Why?
|
| Benzamides | 5 | 2013 | 1371 | 0.420 |
Why?
|
| Melanocyte-Stimulating Hormones | 4 | 2021 | 25 | 0.420 |
Why?
|
| Phenylurea Compounds | 1 | 2016 | 529 | 0.420 |
Why?
|
| Osteoclasts | 4 | 2005 | 711 | 0.410 |
Why?
|
| Hepatocyte Growth Factor | 4 | 2014 | 271 | 0.400 |
Why?
|
| Inhibitor of Apoptosis Proteins | 1 | 2013 | 198 | 0.400 |
Why?
|
| YY1 Transcription Factor | 1 | 2012 | 60 | 0.400 |
Why?
|
| Receptors, Vascular Endothelial Growth Factor | 1 | 2015 | 664 | 0.400 |
Why?
|
| Cyclic AMP | 4 | 2021 | 1463 | 0.390 |
Why?
|
| Vitamin D Deficiency | 1 | 2021 | 1388 | 0.380 |
Why?
|
| Behavior | 2 | 2011 | 540 | 0.370 |
Why?
|
| Drug Discovery | 2 | 2017 | 1051 | 0.370 |
Why?
|
| Sulfones | 3 | 2011 | 447 | 0.370 |
Why?
|
| Stress, Psychological | 3 | 2021 | 4488 | 0.370 |
Why?
|
| Cyclic Nucleotide Phosphodiesterases, Type 4 | 1 | 2010 | 41 | 0.360 |
Why?
|
| Immunologic Factors | 1 | 2020 | 1589 | 0.360 |
Why?
|
| Hypoxia-Inducible Factor 1 | 1 | 2011 | 193 | 0.360 |
Why?
|
| Hydroxamic Acids | 2 | 2016 | 481 | 0.360 |
Why?
|
| Antibodies, Monoclonal | 5 | 2017 | 9172 | 0.350 |
Why?
|
| Proto-Oncogene Proteins | 8 | 2014 | 4512 | 0.350 |
Why?
|
| Mucous Membrane | 2 | 2013 | 659 | 0.350 |
Why?
|
| Mutagenesis | 1 | 2014 | 1230 | 0.350 |
Why?
|
| Chromatin Immunoprecipitation | 7 | 2011 | 852 | 0.350 |
Why?
|
| Transforming Growth Factor beta3 | 1 | 2010 | 44 | 0.340 |
Why?
|
| Neoplasm Recurrence, Local | 4 | 2022 | 9277 | 0.340 |
Why?
|
| Mitochondria | 5 | 2021 | 3619 | 0.340 |
Why?
|
| Tumor Suppressor Protein p53 | 4 | 2014 | 2917 | 0.340 |
Why?
|
| Dermatitis, Atopic | 1 | 2017 | 731 | 0.340 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 7 | 2015 | 3777 | 0.340 |
Why?
|
| Hair | 3 | 2021 | 498 | 0.340 |
Why?
|
| Cell Survival | 11 | 2019 | 5780 | 0.340 |
Why?
|
| Iron | 1 | 2018 | 1790 | 0.330 |
Why?
|
| Transforming Growth Factor beta2 | 1 | 2010 | 71 | 0.330 |
Why?
|
| Ribonuclease III | 2 | 2011 | 279 | 0.320 |
Why?
|
| Apoptosis Regulatory Proteins | 3 | 2015 | 1134 | 0.320 |
Why?
|
| Apoptosis | 12 | 2021 | 9476 | 0.320 |
Why?
|
| Xenograft Model Antitumor Assays | 9 | 2019 | 3599 | 0.310 |
Why?
|
| Melanoma, Experimental | 5 | 2023 | 561 | 0.310 |
Why?
|
| alpha-MSH | 3 | 2012 | 71 | 0.310 |
Why?
|
| Base Sequence | 15 | 2023 | 12421 | 0.310 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 4 | 2017 | 11736 | 0.300 |
Why?
|
| Analgesics, Opioid | 2 | 2021 | 3805 | 0.300 |
Why?
|
| Oxidoreductases | 3 | 2014 | 412 | 0.300 |
Why?
|
| Oncogene Proteins, Fusion | 5 | 2023 | 1608 | 0.300 |
Why?
|
| Protein Kinases | 4 | 2020 | 1606 | 0.290 |
Why?
|
| Tumor Cells, Cultured | 8 | 2021 | 6126 | 0.290 |
Why?
|
| Endopeptidases | 1 | 2011 | 774 | 0.290 |
Why?
|
| Neoplasm Metastasis | 11 | 2016 | 4910 | 0.290 |
Why?
|
| Helix-Loop-Helix Motifs | 2 | 2004 | 96 | 0.280 |
Why?
|
| Blotting, Western | 10 | 2015 | 5034 | 0.280 |
Why?
|
| Interferon Regulatory Factors | 2 | 2021 | 261 | 0.270 |
Why?
|
| High Mobility Group Proteins | 2 | 2006 | 177 | 0.270 |
Why?
|
| Nucleosomes | 2 | 2008 | 487 | 0.270 |
Why?
|
| Biomedical Research | 4 | 2021 | 3426 | 0.270 |
Why?
|
| Activating Transcription Factor 1 | 1 | 2006 | 26 | 0.270 |
Why?
|
| MAP Kinase Signaling System | 6 | 2021 | 1483 | 0.270 |
Why?
|
| Up-Regulation | 8 | 2017 | 4117 | 0.270 |
Why?
|
| Pathology | 1 | 2009 | 269 | 0.270 |
Why?
|
| Immunity, Innate | 2 | 2016 | 3045 | 0.270 |
Why?
|
| Opioid-Related Disorders | 1 | 2021 | 2164 | 0.260 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 11 | 2013 | 4570 | 0.260 |
Why?
|
| Antigens, Neoplasm | 4 | 2021 | 1985 | 0.260 |
Why?
|
| Hyperpigmentation | 1 | 2007 | 116 | 0.250 |
Why?
|
| Mice, Nude | 8 | 2019 | 3605 | 0.250 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2011 | 1133 | 0.250 |
Why?
|
| Administration, Topical | 3 | 2017 | 703 | 0.250 |
Why?
|
| Translocation, Genetic | 3 | 2011 | 1392 | 0.250 |
Why?
|
| TRPM Cation Channels | 3 | 2021 | 139 | 0.250 |
Why?
|
| Autoimmune Diseases | 1 | 2017 | 2238 | 0.240 |
Why?
|
| SUMO-1 Protein | 1 | 2004 | 35 | 0.240 |
Why?
|
| RNA-Binding Protein EWS | 1 | 2006 | 210 | 0.240 |
Why?
|
| CDC2-CDC28 Kinases | 1 | 2004 | 110 | 0.240 |
Why?
|
| Homeodomain Proteins | 3 | 2011 | 2413 | 0.240 |
Why?
|
| Computational Biology | 1 | 2016 | 3509 | 0.240 |
Why?
|
| Genes, p53 | 1 | 2007 | 712 | 0.240 |
Why?
|
| Transfection | 9 | 2015 | 5766 | 0.230 |
Why?
|
| Cell Line, Transformed | 3 | 2018 | 866 | 0.230 |
Why?
|
| Leucine Zippers | 1 | 2004 | 116 | 0.230 |
Why?
|
| Spectrum Analysis, Raman | 2 | 2016 | 237 | 0.230 |
Why?
|
| Gastrointestinal Stromal Tumors | 1 | 2010 | 617 | 0.230 |
Why?
|
| Neoplasm Transplantation | 3 | 2022 | 2010 | 0.230 |
Why?
|
| Membrane Glycoproteins | 6 | 2014 | 3688 | 0.230 |
Why?
|
| Receptors, Notch | 1 | 2008 | 743 | 0.220 |
Why?
|
| Molecular Sequence Data | 12 | 2014 | 17629 | 0.220 |
Why?
|
| Chromosomes, Human, Pair 11 | 2 | 2005 | 410 | 0.210 |
Why?
|
| Chromosomes, Human, Pair 6 | 2 | 2005 | 367 | 0.210 |
Why?
|
| Neoplasms | 9 | 2024 | 22131 | 0.210 |
Why?
|
| Models, Genetic | 7 | 2014 | 3431 | 0.210 |
Why?
|
| Light | 1 | 2008 | 1352 | 0.200 |
Why?
|
| Receptors, Retinoic Acid | 2 | 2016 | 224 | 0.200 |
Why?
|
| Disease Progression | 5 | 2017 | 13495 | 0.200 |
Why?
|
| Drug Delivery Systems | 4 | 2020 | 2222 | 0.200 |
Why?
|
| Mice, Knockout | 6 | 2019 | 14389 | 0.200 |
Why?
|
| Protein Binding | 10 | 2018 | 9345 | 0.200 |
Why?
|
| Introns | 3 | 2011 | 968 | 0.200 |
Why?
|
| Lysosomal Storage Diseases | 1 | 2002 | 79 | 0.200 |
Why?
|
| Interferon Regulatory Factor-1 | 1 | 2021 | 68 | 0.190 |
Why?
|
| Receptors, Calcitriol | 1 | 2024 | 360 | 0.190 |
Why?
|
| Health Status Disparities | 1 | 2013 | 1846 | 0.190 |
Why?
|
| Chromatin | 4 | 2008 | 2955 | 0.190 |
Why?
|
| Cathepsins | 1 | 2002 | 241 | 0.190 |
Why?
|
| Energy Metabolism | 3 | 2024 | 2878 | 0.190 |
Why?
|
| Chromosome Mapping | 2 | 2007 | 4611 | 0.180 |
Why?
|
| Osteochondrodysplasias | 1 | 2002 | 182 | 0.180 |
Why?
|
| Cells, Cultured | 10 | 2020 | 18937 | 0.180 |
Why?
|
| Cell Cycle | 4 | 2014 | 2930 | 0.180 |
Why?
|
| Mitogen-Activated Protein Kinase 7 | 1 | 2021 | 66 | 0.180 |
Why?
|
| Gene Fusion | 1 | 2023 | 356 | 0.180 |
Why?
|
| Epidermis | 2 | 2017 | 527 | 0.180 |
Why?
|
| Interferons | 2 | 2022 | 703 | 0.180 |
Why?
|
| Nuclear Proteins | 4 | 2016 | 5789 | 0.180 |
Why?
|
| Receptor, Melanocortin, Type 4 | 1 | 2021 | 129 | 0.180 |
Why?
|
| Ultraviolet Therapy | 1 | 2020 | 84 | 0.180 |
Why?
|
| Muscle, Skeletal | 1 | 2015 | 4947 | 0.180 |
Why?
|
| Cytoskeletal Proteins | 2 | 2003 | 1336 | 0.170 |
Why?
|
| Genome, Human | 2 | 2018 | 4421 | 0.170 |
Why?
|
| NF-E2-Related Factor 2 | 1 | 2023 | 373 | 0.170 |
Why?
|
| Mitogen-Activated Protein Kinases | 5 | 2019 | 1242 | 0.170 |
Why?
|
| RNA Interference | 5 | 2017 | 2830 | 0.170 |
Why?
|
| Phosphorylation | 7 | 2019 | 8311 | 0.170 |
Why?
|
| Autonomic Pathways | 1 | 2020 | 31 | 0.170 |
Why?
|
| Mice, SCID | 4 | 2017 | 2625 | 0.170 |
Why?
|
| RNA, Messenger | 10 | 2021 | 12758 | 0.170 |
Why?
|
| Quinazolines | 2 | 2017 | 1371 | 0.170 |
Why?
|
| Exons | 2 | 2005 | 2381 | 0.170 |
Why?
|
| Protein Processing, Post-Translational | 4 | 2014 | 1971 | 0.170 |
Why?
|
| RNA, Small Interfering | 5 | 2017 | 3419 | 0.170 |
Why?
|
| Immune Evasion | 1 | 2023 | 363 | 0.160 |
Why?
|
| Cysteine | 1 | 2024 | 891 | 0.160 |
Why?
|
| NAD | 3 | 2023 | 614 | 0.160 |
Why?
|
| Rectal Neoplasms | 1 | 2008 | 1156 | 0.160 |
Why?
|
| Nicotinamide Phosphoribosyltransferase | 2 | 2017 | 83 | 0.160 |
Why?
|
| Adrenocorticotropic Hormone | 1 | 2020 | 618 | 0.160 |
Why?
|
| Heat-Shock Proteins | 2 | 2013 | 795 | 0.160 |
Why?
|
| DNA Primers | 3 | 2011 | 2817 | 0.160 |
Why?
|
| Trans-Activators | 4 | 2015 | 2852 | 0.160 |
Why?
|
| Vitamin D | 4 | 2023 | 3302 | 0.150 |
Why?
|
| Cytoprotection | 1 | 2018 | 200 | 0.150 |
Why?
|
| Receptors, CXCR3 | 1 | 2019 | 238 | 0.150 |
Why?
|
| Mice, Transgenic | 6 | 2017 | 9529 | 0.150 |
Why?
|
| MSX1 Transcription Factor | 1 | 2017 | 53 | 0.150 |
Why?
|
| Paracrine Communication | 1 | 2019 | 277 | 0.150 |
Why?
|
| rho-Associated Kinases | 1 | 2019 | 281 | 0.150 |
Why?
|
| AMP-Activated Protein Kinases | 2 | 2018 | 597 | 0.150 |
Why?
|
| Administration, Cutaneous | 1 | 2020 | 712 | 0.140 |
Why?
|
| RNA Stability | 1 | 2019 | 320 | 0.140 |
Why?
|
| Inflammation | 1 | 2017 | 10760 | 0.140 |
Why?
|
| Serum | 1 | 2018 | 208 | 0.140 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2019 | 433 | 0.140 |
Why?
|
| Luciferases | 4 | 2008 | 712 | 0.140 |
Why?
|
| Oxidative Stress | 3 | 2023 | 3113 | 0.140 |
Why?
|
| Prognosis | 7 | 2021 | 29600 | 0.140 |
Why?
|
| Hepatocytes | 1 | 2024 | 1231 | 0.140 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 2 | 1 | 2017 | 51 | 0.140 |
Why?
|
| Melanoma, Amelanotic | 1 | 2016 | 19 | 0.140 |
Why?
|
| 3T3-L1 Cells | 1 | 2017 | 209 | 0.140 |
Why?
|
| Tumor Escape | 2 | 2017 | 371 | 0.140 |
Why?
|
| gp100 Melanoma Antigen | 3 | 2010 | 38 | 0.140 |
Why?
|
| Disease Models, Animal | 8 | 2022 | 18221 | 0.140 |
Why?
|
| Sympathetic Nervous System | 1 | 2020 | 519 | 0.140 |
Why?
|
| Myosin Type V | 1 | 2016 | 32 | 0.140 |
Why?
|
| Genes, Reporter | 4 | 2004 | 1525 | 0.140 |
Why?
|
| Quantitative Trait Loci | 1 | 2005 | 2112 | 0.140 |
Why?
|
| Models, Animal | 2 | 2014 | 2109 | 0.130 |
Why?
|
| Stem Cell Niche | 1 | 2020 | 344 | 0.130 |
Why?
|
| Intramolecular Oxidoreductases | 2 | 2014 | 105 | 0.130 |
Why?
|
| Female | 27 | 2020 | 392148 | 0.130 |
Why?
|
| Mice, Inbred NOD | 2 | 2017 | 1827 | 0.130 |
Why?
|
| Membrane Transport Proteins | 1 | 2001 | 1034 | 0.130 |
Why?
|
| Antigens, Nuclear | 1 | 2016 | 184 | 0.130 |
Why?
|
| Sequence Analysis, DNA | 1 | 2007 | 4739 | 0.130 |
Why?
|
| Cytokines | 4 | 2017 | 7373 | 0.130 |
Why?
|
| Mitochondrial Proteins | 1 | 2021 | 974 | 0.130 |
Why?
|
| Neostriatum | 1 | 2017 | 247 | 0.130 |
Why?
|
| Endoplasmic Reticulum | 1 | 2021 | 1132 | 0.130 |
Why?
|
| Carrier Proteins | 3 | 2012 | 4935 | 0.120 |
Why?
|
| Ligands | 2 | 2024 | 3268 | 0.120 |
Why?
|
| Immunomodulation | 1 | 2019 | 548 | 0.120 |
Why?
|
| Sarcoma, Alveolar Soft Part | 1 | 2015 | 43 | 0.120 |
Why?
|
| Immunoblotting | 2 | 2010 | 1646 | 0.120 |
Why?
|
| Myosin Heavy Chains | 1 | 2016 | 404 | 0.120 |
Why?
|
| Substantia Nigra | 1 | 2017 | 350 | 0.120 |
Why?
|
| Interferon-gamma | 2 | 2023 | 3145 | 0.120 |
Why?
|
| Oximes | 2 | 2014 | 303 | 0.120 |
Why?
|
| Down-Regulation | 3 | 2012 | 2915 | 0.120 |
Why?
|
| Oxidative Phosphorylation | 2 | 2014 | 495 | 0.120 |
Why?
|
| Eczema | 1 | 2017 | 246 | 0.120 |
Why?
|
| Melanosomes | 2 | 2021 | 33 | 0.120 |
Why?
|
| Purines | 2 | 2011 | 606 | 0.120 |
Why?
|
| Immunohistochemistry | 6 | 2016 | 11069 | 0.120 |
Why?
|
| Adipogenesis | 1 | 2017 | 366 | 0.120 |
Why?
|
| Tanning | 1 | 2014 | 10 | 0.120 |
Why?
|
| Coculture Techniques | 2 | 2019 | 1336 | 0.120 |
Why?
|
| Epitopes | 1 | 2021 | 2501 | 0.120 |
Why?
|
| Binding Sites | 6 | 2018 | 6051 | 0.120 |
Why?
|
| Dacarbazine | 1 | 2017 | 559 | 0.120 |
Why?
|
| Kidney Neoplasms | 3 | 2011 | 4250 | 0.120 |
Why?
|
| Lymphocytes, Tumor-Infiltrating | 2 | 2017 | 1088 | 0.110 |
Why?
|
| NF-kappa B p50 Subunit | 1 | 2014 | 103 | 0.110 |
Why?
|
| Aging | 2 | 2021 | 8699 | 0.110 |
Why?
|
| Risk Factors | 7 | 2023 | 74115 | 0.110 |
Why?
|
| Sequence Homology, Nucleic Acid | 1 | 2014 | 1058 | 0.110 |
Why?
|
| Cell Nucleus | 3 | 2015 | 2894 | 0.110 |
Why?
|
| Male | 23 | 2020 | 360358 | 0.110 |
Why?
|
| Butadienes | 2 | 2010 | 107 | 0.110 |
Why?
|
| Flow Cytometry | 5 | 2023 | 5863 | 0.110 |
Why?
|
| Antineoplastic Agents, Alkylating | 1 | 2017 | 617 | 0.110 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2018 | 988 | 0.110 |
Why?
|
| HeLa Cells | 5 | 2015 | 3087 | 0.110 |
Why?
|
| Suntan | 1 | 2012 | 17 | 0.110 |
Why?
|
| Fibroblasts | 4 | 2018 | 4137 | 0.110 |
Why?
|
| Melanoma-Specific Antigens | 1 | 2013 | 74 | 0.110 |
Why?
|
| Vitamins | 1 | 2021 | 1635 | 0.100 |
Why?
|
| Osteopetrosis | 2 | 2002 | 43 | 0.100 |
Why?
|
| Peroxidases | 1 | 2012 | 134 | 0.100 |
Why?
|
| Drug Eruptions | 1 | 2015 | 335 | 0.100 |
Why?
|
| Carcinoma, Basal Cell | 2 | 2009 | 557 | 0.100 |
Why?
|
| Quail | 1 | 2011 | 40 | 0.100 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2001 | 1894 | 0.100 |
Why?
|
| Societies, Scientific | 2 | 2016 | 222 | 0.100 |
Why?
|
| Cloning, Molecular | 3 | 2008 | 4172 | 0.100 |
Why?
|
| Minor Histocompatibility Antigens | 1 | 2013 | 293 | 0.100 |
Why?
|
| Receptors, Transforming Growth Factor beta | 2 | 2010 | 302 | 0.100 |
Why?
|
| Chick Embryo | 2 | 2011 | 982 | 0.100 |
Why?
|
| Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2015 | 888 | 0.090 |
Why?
|
| Adiponectin | 1 | 2017 | 1107 | 0.090 |
Why?
|
| Drug Synergism | 1 | 2015 | 1755 | 0.090 |
Why?
|
| T-Lymphocytes | 4 | 2023 | 10175 | 0.090 |
Why?
|
| Cyclic Nucleotide Phosphodiesterases, Type 5 | 1 | 2011 | 32 | 0.090 |
Why?
|
| Models, Biological | 5 | 2019 | 9461 | 0.090 |
Why?
|
| Homeostasis | 3 | 2024 | 3321 | 0.090 |
Why?
|
| Rolipram | 1 | 2010 | 24 | 0.090 |
Why?
|
| Genomics | 4 | 2023 | 5822 | 0.090 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2018 | 1250 | 0.090 |
Why?
|
| Histocompatibility Antigens Class I | 1 | 2017 | 1348 | 0.090 |
Why?
|
| Molecular Diagnostic Techniques | 1 | 2015 | 610 | 0.090 |
Why?
|
| Fluorescent Antibody Technique | 2 | 2013 | 2467 | 0.090 |
Why?
|
| Phosphodiesterase 4 Inhibitors | 1 | 2010 | 34 | 0.090 |
Why?
|
| Glutathione | 1 | 2013 | 582 | 0.090 |
Why?
|
| Imidazoles | 2 | 2014 | 1175 | 0.090 |
Why?
|
| Cyclin-Dependent Kinases | 2 | 2004 | 655 | 0.090 |
Why?
|
| Microscopy | 1 | 2015 | 905 | 0.090 |
Why?
|
| Minors | 1 | 2010 | 58 | 0.090 |
Why?
|
| Cell Death | 1 | 2015 | 1677 | 0.090 |
Why?
|
| Parkinson Disease | 2 | 2022 | 2878 | 0.090 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 1 | 2013 | 638 | 0.090 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 1 | 1 | 2010 | 96 | 0.090 |
Why?
|
| Phosphodiesterase 5 Inhibitors | 1 | 2011 | 103 | 0.090 |
Why?
|
| Adenoviridae | 2 | 2006 | 1084 | 0.090 |
Why?
|
| Gene Expression Profiling | 2 | 2016 | 9417 | 0.090 |
Why?
|
| Thiazoles | 1 | 2017 | 1517 | 0.090 |
Why?
|
| B-Lymphocytes | 1 | 2023 | 4745 | 0.080 |
Why?
|
| NFATC Transcription Factors | 3 | 2010 | 389 | 0.080 |
Why?
|
| Molecular Imaging | 1 | 2016 | 814 | 0.080 |
Why?
|
| Stress, Physiological | 1 | 2017 | 1403 | 0.080 |
Why?
|
| Phosphodiesterase Inhibitors | 1 | 2010 | 214 | 0.080 |
Why?
|
| Autophagy | 2 | 2015 | 1326 | 0.080 |
Why?
|
| Chromosomes, Human, X | 1 | 2011 | 321 | 0.080 |
Why?
|
| Cell Hypoxia | 1 | 2011 | 656 | 0.080 |
Why?
|
| Beauty Culture | 1 | 2009 | 41 | 0.080 |
Why?
|
| Tumor Microenvironment | 3 | 2023 | 3868 | 0.080 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2023 | 2249 | 0.080 |
Why?
|
| Particle Size | 1 | 2013 | 1648 | 0.080 |
Why?
|
| Gene Knockdown Techniques | 2 | 2010 | 1608 | 0.080 |
Why?
|
| Cell Movement | 6 | 2017 | 5200 | 0.080 |
Why?
|
| Sulfotransferases | 1 | 2009 | 150 | 0.080 |
Why?
|
| Epigenesis, Genetic | 3 | 2019 | 3794 | 0.080 |
Why?
|
| Cell Division | 5 | 2015 | 4457 | 0.080 |
Why?
|
| Plasmids | 2 | 2011 | 2265 | 0.080 |
Why?
|
| Noonan Syndrome | 2 | 2010 | 120 | 0.080 |
Why?
|
| MART-1 Antigen | 2 | 2010 | 63 | 0.080 |
Why?
|
| Gene Expression Regulation, Developmental | 3 | 2012 | 3608 | 0.080 |
Why?
|
| Gene Silencing | 1 | 2014 | 1503 | 0.080 |
Why?
|
| Feedback, Physiological | 1 | 2010 | 475 | 0.080 |
Why?
|
| Neoplasm Seeding | 1 | 2008 | 84 | 0.070 |
Why?
|
| Nitriles | 2 | 2010 | 971 | 0.070 |
Why?
|
| Drug Design | 1 | 2013 | 1045 | 0.070 |
Why?
|
| Spheroids, Cellular | 2 | 2023 | 329 | 0.070 |
Why?
|
| Gene Targeting | 1 | 2011 | 837 | 0.070 |
Why?
|
| Clinical Trials as Topic | 3 | 2015 | 7995 | 0.070 |
Why?
|
| Immunoprecipitation | 1 | 2010 | 876 | 0.070 |
Why?
|
| Drug Approval | 1 | 2014 | 812 | 0.070 |
Why?
|
| In Situ Hybridization, Fluorescence | 2 | 2011 | 2509 | 0.070 |
Why?
|
| Microscopy, Fluorescence | 1 | 2014 | 2639 | 0.070 |
Why?
|
| Cancer Vaccines | 1 | 2015 | 1037 | 0.070 |
Why?
|
| Neoplastic Cells, Circulating | 1 | 2014 | 943 | 0.070 |
Why?
|
| Foreskin | 1 | 2007 | 33 | 0.070 |
Why?
|
| Cell Shape | 2 | 2005 | 369 | 0.070 |
Why?
|
| Polymerase Chain Reaction | 2 | 2014 | 6074 | 0.070 |
Why?
|
| RNA Splicing | 1 | 2011 | 898 | 0.070 |
Why?
|
| Pro-Opiomelanocortin | 1 | 2007 | 140 | 0.070 |
Why?
|
| Tumor Suppressor Proteins | 2 | 2014 | 2801 | 0.070 |
Why?
|
| Ubiquitination | 1 | 2011 | 1006 | 0.070 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 1 | 2014 | 1626 | 0.070 |
Why?
|
| Oxidation-Reduction | 2 | 2024 | 2231 | 0.070 |
Why?
|
| RNA, Neoplasm | 1 | 2009 | 749 | 0.070 |
Why?
|
| Genes, Tumor Suppressor | 1 | 2010 | 1056 | 0.070 |
Why?
|
| Transplantation, Heterologous | 2 | 2011 | 2382 | 0.070 |
Why?
|
| Algorithms | 1 | 2007 | 14018 | 0.070 |
Why?
|
| Advisory Committees | 1 | 2010 | 787 | 0.070 |
Why?
|
| Feasibility Studies | 1 | 2017 | 5239 | 0.070 |
Why?
|
| Soft Tissue Neoplasms | 1 | 2015 | 1158 | 0.070 |
Why?
|
| Genes, p16 | 1 | 2006 | 160 | 0.070 |
Why?
|
| Molecular Biology | 1 | 2009 | 575 | 0.060 |
Why?
|
| T-Lymphocytes, Cytotoxic | 1 | 2013 | 1779 | 0.060 |
Why?
|
| HEK293 Cells | 4 | 2017 | 4269 | 0.060 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 2 | 2014 | 2872 | 0.060 |
Why?
|
| Genetic Predisposition to Disease | 4 | 2021 | 17878 | 0.060 |
Why?
|
| Antibiotics, Antineoplastic | 1 | 2009 | 678 | 0.060 |
Why?
|
| Polymorphism, Single Nucleotide | 6 | 2021 | 15908 | 0.060 |
Why?
|
| E-Box Elements | 1 | 2004 | 20 | 0.060 |
Why?
|
| Biopsy | 1 | 2017 | 6762 | 0.060 |
Why?
|
| Antioxidants | 1 | 2013 | 1668 | 0.060 |
Why?
|
| Antigen Presentation | 2 | 2023 | 1250 | 0.060 |
Why?
|
| Anastomosis, Surgical | 1 | 2008 | 982 | 0.060 |
Why?
|
| DNA Repair | 1 | 2014 | 2043 | 0.060 |
Why?
|
| Pigment Epithelium of Eye | 1 | 2005 | 209 | 0.060 |
Why?
|
| Cyclin-Dependent Kinase 2 | 1 | 2004 | 184 | 0.060 |
Why?
|
| Survival Rate | 2 | 2021 | 12719 | 0.060 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2023 | 5319 | 0.060 |
Why?
|
| Vibrissae | 1 | 2004 | 116 | 0.060 |
Why?
|
| Multigene Family | 1 | 2007 | 1076 | 0.060 |
Why?
|
| Interdisciplinary Communication | 1 | 2009 | 928 | 0.060 |
Why?
|
| DNA | 2 | 2015 | 7196 | 0.060 |
Why?
|
| Mutagenesis, Site-Directed | 2 | 2005 | 1692 | 0.060 |
Why?
|
| Young Adult | 6 | 2023 | 59179 | 0.050 |
Why?
|
| Pigments, Biological | 1 | 2003 | 52 | 0.050 |
Why?
|
| S Phase | 1 | 2004 | 421 | 0.050 |
Why?
|
| Tumor Stem Cell Assay | 1 | 2003 | 115 | 0.050 |
Why?
|
| Practice Guidelines as Topic | 1 | 2021 | 7389 | 0.050 |
Why?
|
| 25-Hydroxyvitamin D3 1-alpha-Hydroxylase | 1 | 2023 | 58 | 0.050 |
Why?
|
| Carcinoma, Renal Cell | 2 | 2011 | 3164 | 0.050 |
Why?
|
| Aged, 80 and over | 4 | 2014 | 58894 | 0.050 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2015 | 3634 | 0.050 |
Why?
|
| Genes, Dominant | 1 | 2006 | 851 | 0.050 |
Why?
|
| Cell Line | 4 | 2021 | 15576 | 0.050 |
Why?
|
| Immune System | 1 | 2008 | 791 | 0.050 |
Why?
|
| Cell Separation | 2 | 2014 | 1718 | 0.050 |
Why?
|
| bcl-X Protein | 1 | 2004 | 410 | 0.050 |
Why?
|
| Time Factors | 6 | 2018 | 39913 | 0.050 |
Why?
|
| Tumor Necrosis Factors | 1 | 2023 | 107 | 0.050 |
Why?
|
| Analysis of Variance | 1 | 2011 | 6224 | 0.050 |
Why?
|
| Dendritic Cells | 1 | 2014 | 2722 | 0.050 |
Why?
|
| Cathepsin K | 1 | 2002 | 63 | 0.050 |
Why?
|
| Protein Tyrosine Phosphatases | 1 | 2004 | 457 | 0.050 |
Why?
|
| Forkhead Transcription Factors | 1 | 2010 | 1614 | 0.050 |
Why?
|
| Enhancer Elements, Genetic | 2 | 2013 | 1360 | 0.050 |
Why?
|
| NF-kappa B | 2 | 2024 | 2481 | 0.050 |
Why?
|
| Cooperative Behavior | 1 | 2009 | 1504 | 0.050 |
Why?
|
| Lymphoid Enhancer-Binding Factor 1 | 1 | 2002 | 84 | 0.050 |
Why?
|
| Protein Synthesis Inhibitors | 1 | 2002 | 189 | 0.050 |
Why?
|
| Glioma | 1 | 2017 | 3453 | 0.050 |
Why?
|
| Adult | 11 | 2018 | 220969 | 0.050 |
Why?
|
| STAT Transcription Factors | 1 | 2023 | 188 | 0.050 |
Why?
|
| Eye Abnormalities | 1 | 2004 | 242 | 0.050 |
Why?
|
| Sirolimus | 1 | 2009 | 1533 | 0.050 |
Why?
|
| Cycloheximide | 1 | 2002 | 343 | 0.050 |
Why?
|
| United States Food and Drug Administration | 1 | 2010 | 1661 | 0.050 |
Why?
|
| Crystallins | 1 | 2001 | 75 | 0.050 |
Why?
|
| Data Collection | 1 | 2011 | 3315 | 0.050 |
Why?
|
| Germ-Line Mutation | 1 | 2010 | 1852 | 0.050 |
Why?
|
| Janus Kinases | 1 | 2023 | 248 | 0.050 |
Why?
|
| International Cooperation | 1 | 2008 | 1421 | 0.050 |
Why?
|
| Cell Communication | 1 | 2008 | 1654 | 0.050 |
Why?
|
| CD8-Positive T-Lymphocytes | 3 | 2023 | 4571 | 0.050 |
Why?
|
| Alternative Splicing | 1 | 2006 | 1088 | 0.050 |
Why?
|
| Mutation, Missense | 2 | 2014 | 2570 | 0.050 |
Why?
|
| Peptides | 1 | 2013 | 4354 | 0.050 |
Why?
|
| Pyrimidinones | 2 | 2014 | 385 | 0.050 |
Why?
|
| Morphogenesis | 1 | 2004 | 741 | 0.050 |
Why?
|
| beta Catenin | 2 | 2003 | 1039 | 0.050 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2010 | 2425 | 0.040 |
Why?
|
| DNA Methylation | 1 | 2015 | 4391 | 0.040 |
Why?
|
| Glioblastoma | 1 | 2015 | 3481 | 0.040 |
Why?
|
| Lymphocyte Activation | 2 | 2023 | 5463 | 0.040 |
Why?
|
| Receptors, Antigen, B-Cell | 1 | 2023 | 544 | 0.040 |
Why?
|
| Protein Isoforms | 1 | 2005 | 1697 | 0.040 |
Why?
|
| Organ Specificity | 1 | 2005 | 1964 | 0.040 |
Why?
|
| Antibodies, Neutralizing | 1 | 2010 | 1936 | 0.040 |
Why?
|
| Diterpenes | 1 | 2020 | 170 | 0.040 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2008 | 3730 | 0.040 |
Why?
|
| Tristetraprolin | 1 | 2019 | 38 | 0.040 |
Why?
|
| Lysine | 1 | 2004 | 993 | 0.040 |
Why?
|
| Aged | 6 | 2014 | 169042 | 0.040 |
Why?
|
| Survival Analysis | 1 | 2012 | 10073 | 0.040 |
Why?
|
| Caspases | 1 | 2023 | 878 | 0.040 |
Why?
|
| Luminescent Proteins | 1 | 2002 | 836 | 0.040 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2018 | 5672 | 0.040 |
Why?
|
| Cell Culture Techniques | 1 | 2007 | 1662 | 0.040 |
Why?
|
| Interferon Type I | 1 | 2023 | 557 | 0.040 |
Why?
|
| Stem Cell Factor | 1 | 2019 | 195 | 0.040 |
Why?
|
| Denervation | 1 | 2020 | 265 | 0.040 |
Why?
|
| Symporters | 1 | 2001 | 363 | 0.040 |
Why?
|
| Receptors, Adrenergic, beta-2 | 1 | 2020 | 217 | 0.040 |
Why?
|
| Base Composition | 1 | 2018 | 290 | 0.040 |
Why?
|
| Middle Aged | 8 | 2015 | 220584 | 0.040 |
Why?
|
| Lung Neoplasms | 1 | 2023 | 13382 | 0.040 |
Why?
|
| Risk | 1 | 2010 | 9604 | 0.040 |
Why?
|
| Chronic Disease | 1 | 2013 | 9311 | 0.040 |
Why?
|
| Muscle Proteins | 1 | 2003 | 1152 | 0.040 |
Why?
|
| Kinetics | 1 | 2006 | 6370 | 0.040 |
Why?
|
| Animals, Genetically Modified | 2 | 2018 | 1557 | 0.040 |
Why?
|
| Pyridones | 2 | 2014 | 808 | 0.040 |
Why?
|
| Health Policy | 1 | 2010 | 2682 | 0.040 |
Why?
|
| Gene Rearrangement | 1 | 2003 | 1125 | 0.040 |
Why?
|
| Adrenalectomy | 1 | 2020 | 346 | 0.040 |
Why?
|
| Nail Diseases | 1 | 2018 | 55 | 0.040 |
Why?
|
| Mast Cells | 1 | 2005 | 1392 | 0.040 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2002 | 2495 | 0.040 |
Why?
|
| Genetic Vectors | 2 | 2005 | 3392 | 0.040 |
Why?
|
| Culture Media | 1 | 2019 | 895 | 0.040 |
Why?
|
| Adrenal Glands | 1 | 2020 | 552 | 0.040 |
Why?
|
| Tumor Burden | 1 | 2023 | 1892 | 0.040 |
Why?
|
| Kaplan-Meier Estimate | 2 | 2018 | 6474 | 0.040 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 2 | 2015 | 3800 | 0.040 |
Why?
|
| Norepinephrine | 1 | 2020 | 898 | 0.040 |
Why?
|
| 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine | 1 | 2017 | 89 | 0.040 |
Why?
|
| Treatment Outcome | 4 | 2016 | 64568 | 0.040 |
Why?
|
| Gene Expression | 2 | 2012 | 7568 | 0.040 |
Why?
|
| NIH 3T3 Cells | 1 | 2018 | 669 | 0.030 |
Why?
|
| Green Fluorescent Proteins | 1 | 2002 | 2063 | 0.030 |
Why?
|
| Dual Specificity Phosphatase 6 | 1 | 2016 | 13 | 0.030 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 11 | 2 | 2010 | 223 | 0.030 |
Why?
|
| Amides | 1 | 2019 | 449 | 0.030 |
Why?
|
| Osteoblasts | 1 | 2002 | 1141 | 0.030 |
Why?
|
| Organoids | 1 | 2023 | 744 | 0.030 |
Why?
|
| Receptors, Nerve Growth Factor | 1 | 2017 | 198 | 0.030 |
Why?
|
| Protein Structure, Tertiary | 1 | 2003 | 3792 | 0.030 |
Why?
|
| Parathyroid Hormone | 1 | 2023 | 1803 | 0.030 |
Why?
|
| Ubiquitin | 1 | 2021 | 839 | 0.030 |
Why?
|
| Fatty Acids | 1 | 2024 | 1808 | 0.030 |
Why?
|
| Amino Acid Motifs | 1 | 2018 | 927 | 0.030 |
Why?
|
| Dermis | 1 | 2017 | 202 | 0.030 |
Why?
|
| Pentosyltransferases | 1 | 2015 | 62 | 0.030 |
Why?
|
| Ear | 1 | 2016 | 172 | 0.030 |
Why?
|
| Spleen | 1 | 2002 | 2286 | 0.030 |
Why?
|
| Receptors, Cell Surface | 1 | 2005 | 2802 | 0.030 |
Why?
|
| Skin Diseases, Papulosquamous | 1 | 2015 | 17 | 0.030 |
Why?
|
| Amino Acid Sequence | 2 | 2012 | 13441 | 0.030 |
Why?
|
| Neoplasm Staging | 3 | 2016 | 11116 | 0.030 |
Why?
|
| Neurotoxins | 1 | 2017 | 240 | 0.030 |
Why?
|
| Killer Cells, Natural | 1 | 2005 | 2191 | 0.030 |
Why?
|
| Lipid Metabolism | 1 | 2024 | 1896 | 0.030 |
Why?
|
| Hypopigmentation | 1 | 2015 | 43 | 0.030 |
Why?
|
| Acrylamides | 1 | 2017 | 259 | 0.030 |
Why?
|
| Adolescent | 5 | 2023 | 88234 | 0.030 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p18 | 1 | 2015 | 53 | 0.030 |
Why?
|
| alpha-Synuclein | 1 | 2022 | 752 | 0.030 |
Why?
|
| Unfolded Protein Response | 1 | 2017 | 234 | 0.030 |
Why?
|
| Neuroblastoma | 1 | 2003 | 1248 | 0.030 |
Why?
|
| Clone Cells | 1 | 2018 | 1657 | 0.030 |
Why?
|
| Risk Assessment | 1 | 2016 | 23972 | 0.030 |
Why?
|
| Pyridines | 2 | 2019 | 2874 | 0.030 |
Why?
|
| Retreatment | 1 | 2016 | 596 | 0.030 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2021 | 1320 | 0.030 |
Why?
|
| Receptors, Estrogen | 1 | 2023 | 2208 | 0.030 |
Why?
|
| Benzocycloheptenes | 1 | 2014 | 9 | 0.030 |
Why?
|
| Proteins | 2 | 2011 | 6030 | 0.030 |
Why?
|
| Area Under Curve | 1 | 2018 | 1635 | 0.030 |
Why?
|
| GTP-Binding Protein alpha Subunits | 1 | 2015 | 102 | 0.030 |
Why?
|
| Brain Neoplasms | 1 | 2015 | 9026 | 0.030 |
Why?
|
| Pyrimidine Dimers | 1 | 2014 | 18 | 0.030 |
Why?
|
| GTP-Binding Protein alpha Subunits, Gq-G11 | 1 | 2015 | 147 | 0.030 |
Why?
|
| Glutarates | 1 | 2015 | 243 | 0.030 |
Why?
|
| Immunocompetence | 1 | 2014 | 138 | 0.030 |
Why?
|
| Transcription Factor AP-2 | 1 | 2013 | 78 | 0.030 |
Why?
|
| Retina | 1 | 2004 | 2655 | 0.030 |
Why?
|
| Retrospective Studies | 2 | 2020 | 80566 | 0.030 |
Why?
|
| Alopecia | 1 | 2018 | 412 | 0.030 |
Why?
|
| Mice, Mutant Strains | 1 | 2016 | 1748 | 0.030 |
Why?
|
| Gene Deletion | 2 | 2015 | 2661 | 0.030 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2009 | 4020 | 0.030 |
Why?
|
| Adaptation, Biological | 1 | 2014 | 147 | 0.030 |
Why?
|
| RNA-Binding Proteins | 2 | 2012 | 1890 | 0.030 |
Why?
|
| RNA | 1 | 2023 | 2713 | 0.030 |
Why?
|
| Zinc Fingers | 1 | 2015 | 578 | 0.030 |
Why?
|
| Cell Adhesion | 1 | 2019 | 3088 | 0.030 |
Why?
|
| Cadherins | 1 | 2017 | 901 | 0.030 |
Why?
|
| Random Allocation | 1 | 2017 | 2392 | 0.030 |
Why?
|
| Alleles | 1 | 2003 | 6861 | 0.030 |
Why?
|
| Pruritus | 1 | 2015 | 378 | 0.020 |
Why?
|
| Lentivirus | 1 | 2015 | 507 | 0.020 |
Why?
|
| Lymphocyte Count | 1 | 2014 | 778 | 0.020 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2015 | 697 | 0.020 |
Why?
|
| Ribonucleoprotein, U1 Small Nuclear | 1 | 2011 | 36 | 0.020 |
Why?
|
| Combined Modality Therapy | 2 | 2016 | 8516 | 0.020 |
Why?
|
| Bone and Bones | 1 | 2002 | 2565 | 0.020 |
Why?
|
| Lymph Nodes | 1 | 2023 | 3461 | 0.020 |
Why?
|
| Drug Therapy, Combination | 1 | 2021 | 6305 | 0.020 |
Why?
|
| Cyclosporine | 2 | 2005 | 778 | 0.020 |
Why?
|
| Gene Order | 1 | 2011 | 169 | 0.020 |
Why?
|
| Spliceosomes | 1 | 2011 | 119 | 0.020 |
Why?
|
| MAP Kinase Kinase 1 | 1 | 2013 | 332 | 0.020 |
Why?
|
| Sumoylation | 1 | 2011 | 83 | 0.020 |
Why?
|
| Chromosomal Proteins, Non-Histone | 1 | 2016 | 725 | 0.020 |
Why?
|
| Anilides | 1 | 2014 | 411 | 0.020 |
Why?
|
| T-Lymphocyte Subsets | 1 | 2019 | 1798 | 0.020 |
Why?
|
| ROC Curve | 1 | 2018 | 3575 | 0.020 |
Why?
|
| Protein Stability | 1 | 2012 | 578 | 0.020 |
Why?
|
| LEOPARD Syndrome | 1 | 2010 | 12 | 0.020 |
Why?
|
| Microscopy, Confocal | 1 | 2016 | 1970 | 0.020 |
Why?
|
| Diphenylamine | 1 | 2010 | 49 | 0.020 |
Why?
|
| RNA Splice Sites | 1 | 2011 | 210 | 0.020 |
Why?
|
| Infant, Newborn | 1 | 2010 | 26180 | 0.020 |
Why?
|
| Gastrula | 1 | 2010 | 82 | 0.020 |
Why?
|
| Mitosis | 1 | 2015 | 1187 | 0.020 |
Why?
|
| Neural Tube | 1 | 2010 | 48 | 0.020 |
Why?
|
| Calcium | 1 | 2023 | 5717 | 0.020 |
Why?
|
| Enzyme Activation | 1 | 2015 | 3591 | 0.020 |
Why?
|
| Psoriasis | 1 | 2018 | 944 | 0.020 |
Why?
|
| Tamoxifen | 1 | 2014 | 965 | 0.020 |
Why?
|
| Statistics, Nonparametric | 1 | 2015 | 2849 | 0.020 |
Why?
|
| Aniline Compounds | 1 | 2014 | 1068 | 0.020 |
Why?
|
| Leukemia, Myeloid, Acute | 1 | 2004 | 3612 | 0.020 |
Why?
|
| Behavior, Animal | 1 | 2017 | 1872 | 0.020 |
Why?
|
| Benzimidazoles | 1 | 2014 | 858 | 0.020 |
Why?
|
| RNA Processing, Post-Transcriptional | 1 | 2011 | 410 | 0.020 |
Why?
|
| Triazoles | 1 | 2014 | 903 | 0.020 |
Why?
|
| Piperidines | 1 | 2017 | 1655 | 0.020 |
Why?
|
| Quinolines | 1 | 2014 | 764 | 0.020 |
Why?
|
| Liver | 1 | 2024 | 7512 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2014 | 10754 | 0.020 |
Why?
|
| Child | 4 | 2023 | 80079 | 0.020 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2014 | 1113 | 0.020 |
Why?
|
| Open Reading Frames | 1 | 2011 | 813 | 0.020 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2010 | 614 | 0.020 |
Why?
|
| Drug Administration Schedule | 1 | 2015 | 4845 | 0.020 |
Why?
|
| Microfluidic Analytical Techniques | 1 | 2014 | 799 | 0.020 |
Why?
|
| Kidney | 1 | 2023 | 7045 | 0.020 |
Why?
|
| Antigens, CD | 1 | 2017 | 3998 | 0.020 |
Why?
|
| Cohort Studies | 2 | 2021 | 41457 | 0.020 |
Why?
|
| Epitopes, T-Lymphocyte | 1 | 2010 | 825 | 0.020 |
Why?
|
| Metabolomics | 1 | 2015 | 1656 | 0.020 |
Why?
|
| Cell Growth Processes | 1 | 2007 | 384 | 0.020 |
Why?
|
| Sequence Analysis, RNA | 1 | 2014 | 2014 | 0.020 |
Why?
|
| MAP Kinase Kinase 6 | 1 | 2005 | 20 | 0.020 |
Why?
|
| Antineoplastic Agents, Hormonal | 1 | 2014 | 1520 | 0.020 |
Why?
|
| Receptor Activator of Nuclear Factor-kappa B | 1 | 2005 | 77 | 0.020 |
Why?
|
| Repressor Proteins | 1 | 2016 | 2985 | 0.020 |
Why?
|
| SH2 Domain-Containing Protein Tyrosine Phosphatases | 1 | 2004 | 43 | 0.020 |
Why?
|
| COS Cells | 1 | 2007 | 1130 | 0.020 |
Why?
|
| Cell Cycle Proteins | 1 | 2016 | 3447 | 0.010 |
Why?
|
| Inhibitory Concentration 50 | 1 | 2005 | 465 | 0.010 |
Why?
|
| Nerve Tissue Proteins | 1 | 2017 | 4408 | 0.010 |
Why?
|
| Lipids | 1 | 2015 | 3332 | 0.010 |
Why?
|
| Phenotype | 1 | 2002 | 16571 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 3 | 1 | 2005 | 322 | 0.010 |
Why?
|
| src Homology Domains | 1 | 2004 | 361 | 0.010 |
Why?
|
| RANK Ligand | 1 | 2005 | 318 | 0.010 |
Why?
|
| Blotting, Northern | 1 | 2005 | 1545 | 0.010 |
Why?
|
| Genetic Association Studies | 1 | 2012 | 2734 | 0.010 |
Why?
|
| United States | 1 | 2010 | 72272 | 0.010 |
Why?
|
| Precipitin Tests | 1 | 2002 | 813 | 0.010 |
Why?
|
| Liver Neoplasms | 1 | 2017 | 4308 | 0.010 |
Why?
|
| Microscopy, Electron | 1 | 2005 | 2561 | 0.010 |
Why?
|
| Diagnostic Imaging | 1 | 2015 | 3527 | 0.010 |
Why?
|
| Age Factors | 1 | 2018 | 18381 | 0.010 |
Why?
|
| Jurkat Cells | 1 | 2002 | 740 | 0.010 |
Why?
|
| In Situ Hybridization | 1 | 2005 | 1900 | 0.010 |
Why?
|
| CHO Cells | 1 | 2003 | 1387 | 0.010 |
Why?
|
| Gene Dosage | 1 | 2005 | 1217 | 0.010 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2014 | 3077 | 0.010 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2009 | 2057 | 0.010 |
Why?
|
| Cricetinae | 1 | 2003 | 2424 | 0.010 |
Why?
|
| Wnt Proteins | 1 | 2003 | 718 | 0.010 |
Why?
|
| Mesothelioma | 1 | 2005 | 807 | 0.010 |
Why?
|
| DNA, Neoplasm | 1 | 2004 | 1743 | 0.010 |
Why?
|
| Tacrolimus | 1 | 2002 | 733 | 0.010 |
Why?
|
| Cyclin-Dependent Kinase 4 | 1 | 2002 | 561 | 0.010 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2015 | 8998 | 0.010 |
Why?
|
| Saccharomyces cerevisiae | 1 | 2009 | 2674 | 0.010 |
Why?
|
| Protein Biosynthesis | 1 | 2005 | 2100 | 0.010 |
Why?
|
| Histone Deacetylases | 1 | 2002 | 719 | 0.010 |
Why?
|
| Bone Marrow Cells | 1 | 2005 | 2409 | 0.010 |
Why?
|
| Antibodies | 1 | 2005 | 2414 | 0.010 |
Why?
|
| Cell Adhesion Molecules | 1 | 2003 | 1602 | 0.010 |
Why?
|
| Cross-Sectional Studies | 1 | 2018 | 26049 | 0.010 |
Why?
|
| Infant | 1 | 2018 | 36152 | 0.010 |
Why?
|
| Sarcoma | 1 | 2007 | 1800 | 0.010 |
Why?
|
| Genome-Wide Association Study | 1 | 2015 | 12661 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2018 | 42188 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2012 | 22148 | 0.010 |
Why?
|
| Lymphocytes | 1 | 2002 | 2604 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2011 | 20074 | 0.010 |
Why?
|